Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors — Stella

Home/Muscle-Invasive Bladder Carcinoma/Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors

View on ClinicalTrials.gov

Recruiting

Back to Muscle-Invasive Bladder Carcinoma trials

Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Sarcoma Oncology Center, Santa Monica, California

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

Vasgene Therapeutics, Inc

Enrollment target

~700 participants

Started

March 2025

Primary completion

September 2029

Age range

18 Years and older

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.